Vaxzevria® (COVID-19 Vaccine AstraZeneca)

The National Immunisation Office is prioritising keeping the Clinical Guidelines, Bulletins and the Quick Reference Guide up to date. We have limited access to files as a result of the recent cyber attack on our health service. 

The European Medicines Agency authorised the use of the Vaxzevria® (COVID-19 Vaccine AstraZeneca) in January 2021. 

This page contains information to support vaccinators who are administering the Vaxzevria® (COVID-19 Vaccine AstraZeneca) .

AstraZeneca Summary Sheet

Materials for Vaccinators

Please note if you are using TrackVax Vaccine Reconcilliation should be done through this system instead. 

Rates per 100k of deaths from COVID-19 and spontaneous reports of all clotting events

Rates per 100k of ICU from COVID-19 and spontaneous reports of all clotting events

Information from the European Medicines Agency

Information from the World Health Organization

Go to the COVID-19 Page for Health Professionals

This page was updated on 18 June 2021